850157P

16:0-18:1 PI(4)P

Avanti Research^™ - A Croda Brand 850157P, powder

• 同義詞: 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′-phosphate) (ammonium salt)
• 經驗公式（希爾表示法）: C₄₃H₈₈ N₂O₁₆ P₂
• CAS號碼: 2260795-75-1
• 分子量：: 951.11
• 分類程式碼代碼: 51191904
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 mg (with stopper and crimp cap (850157P-1mg)); pkg of 1 × 500 μg (with stopper and crimp cap (850157P-500ug))
• 製造商／商標名: Avanti Research^™ - A Croda Brand 850157P
• 脂質類型: phospholipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]

描述

一般說明

Phosphatidylinositol 4-phosphate (PI4P) is present abundantly at the plasma membrane.

應用

16:0-18:1 PI(4)P (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′-phosphate) (ammonium salt)) has been used in liposomes for phosphatidylinositol 4-phosphate 5-kinase (PIP5K) sedimentation assays.

生化／生理作用

Phosphatidylinositol 4-phosphate (PI(4)P) plays a key role in modulating mitochondrial fission. It participates in protein targeting to the domains of plasma membrane by acting as a spatial cue or signpost.

包裝

2 mL Amber Serum Vial with Stopper and Crimp Cap (850157P-1mg)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850157P-500ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: No data available
• 閃點（°C）: No data available